Convalescent Volunteers
Showing 1 - 25 of >10,000
Coronavirus Disease 19 (COVID-19) Convalescent Plasma
Active, not recruiting
- Asymptomatic COVID-19 Infection Laboratory-Confirmed
- Symptomatic COVID-19 Infection Laboratory-Confirmed
- Biospecimen Collection
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 22, 2022
Plasma From People Who Recovered From or Were Vaccinated to
Enrolling by invitation
- Communicable Diseases
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 27, 2022
SARS-CoV-2 Infection Trial in Nedlands (MTx-COVAB36, Placebo)
Active, not recruiting
- SARS-CoV-2 Infection
- MTx-COVAB36
- Placebo
-
Nedlands, Western Australia, AustraliaLinear Clinical Research
Jul 7, 2022
Covid19 Trial in Kol'tsovo (EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19))
Completed
- Covid19
- EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19)
-
Kol'tsovo, Novosibirsk Region, Russian FederationFederal State Budgetary Institution of Healthcare "Medical and S
Aug 26, 2021
SARS-CoV-2 Infection, Safety and Efficacy Trial in Spain (Convalescent anti-SARS-CoV-2 MBT plasma, Control Group)
Completed
- SARS-CoV-2 Infection
- Safety and Efficacy
- Convalescent anti-SARS-CoV-2 MBT plasma
- Control Group
-
Badalona, Barcelona, Spain
- +3 more
Sep 4, 2021
Transplantation, Hematopoietic Stem Cell Trial in Lyon (Biological samples (blood and oral fluid))
Not yet recruiting
- Transplantation, Hematopoietic Stem Cell
- Biological samples (blood and oral fluid)
-
Lyon, FranceHôpital de la Croix Rousse - service des maladies infectieuses e
Jul 7, 2023
Covid19 Trial in New York (C144-LS and C-135-LS)
Completed
- Covid19
- C144-LS and C-135-LS
-
New York, New YorkThe Rockefeller University
Aug 2, 2022
Sudan Ebola Virus Vaccines Trial (CAd3, ChAdox1, rVSV-SUDV)
Not yet recruiting
- Sudan Ebola Virus Vaccines
- CAd3
- +3 more
- (no location specified)
Jun 8, 2023
COVID-19 Trial in Moscow (MIR 19 ®, Standard COVID-19 therapy)
Completed
- COVID-19
- MIR 19 ®
- Standard COVID-19 therapy
-
Moscow, Russian FederationNRC Institute of Immunology FMBA
Jan 7, 2022
Immunological Profiling of COVID-19 in Respiratory Distress
Recruiting
- SARS-CoV-2
- Covid-19
- Immunological profiling
-
Nîmes, FranceCHU de Nimes
Jun 2, 2022
Ischemic Stroke Trial (MSC)
Not yet recruiting
- Ischemic Stroke
- MSC
- (no location specified)
Jan 24, 2023
SARS-CoV-2 Infection Trial in Mexico City (Recombinant NDV Vectored Vaccine for SARS-CoV-2)
Completed
- SARS-CoV-2 Infection
- Recombinant NDV Vectored Vaccine for SARS-CoV-2
-
Mexico City, Ciudad De Mexico, MexicoHospital Medica Sur
Dec 8, 2022
Covid19 Trial in Ankara, Istanbul, Kocaeli (SARS-CoV-2 VLP Vaccine-Wuhan, SARS-CoV-2 VLP Vaccine-Alpha (British) variant,
Completed
- Covid19
- SARS-CoV-2 VLP Vaccine-Wuhan
- +2 more
-
Ankara, Turkey
- +2 more
May 24, 2022
Covid19 Trial in Helsinki (Convalescent plasma from COVID-19 donors, Placebo)
Active, not recruiting
- Covid19
- Convalescent plasma from COVID-19 donors
- Placebo
-
Helsinki, Uusimaa, FinlandHelsinki University Central Hospital
Jul 2, 2022
COVID-19, Coronavirus, SARS-CoV-2 Trial in United States (pathogen reduced SARS-CoV-2 convalescent plasma, Placebo)
Completed
- COVID-19
- +2 more
- pathogen reduced SARS-CoV-2 convalescent plasma
- Placebo
-
Little Rock, Arkansas
- +25 more
Oct 6, 2022
COVID-19 Trial in France, Germany, United Kingdom (COVID-19 convalescent and vaccinated plasma, Current standard of care)
Recruiting
- COVID-19
- COVID-19 convalescent and vaccinated plasma
- Current standard of care
-
Besançon, France
- +10 more
May 3, 2022
Covid19 Pneumonia Trial in Buenos Aires (COVID19 convalescent plasma infusion)
Completed
- Covid19 Pneumonia
- COVID19 convalescent plasma infusion
-
Buenos Aires, ArgentinaCentro de Educación Médica e Investigaciones Clínicas
Jul 18, 2022
COVID, Corona Virus Infection, Viral Pneumonia Trial in Denmark (Convalescent anti-SARS-CoV-2 plasma, Infusion )
Terminated
- COVID
- +2 more
- Convalescent anti-SARS-CoV-2 plasma
- Infusion placebo
-
Aalborg, Denmark
- +11 more
Aug 2, 2022
COVID-19 Trial in Milwaukee (anti-SARS-CoV-2 convalescent plasma)
Completed
- COVID-19
- anti-SARS-CoV-2 convalescent plasma
-
Milwaukee, WisconsinFroedtert Hospital
Aug 23, 2022
COVID Trial in New Delhi (Convalescent Plasma Transfusion, Supportive Care, Random Donor Plasma)
Completed
- COVID
- Convalescent Plasma Transfusion
- +2 more
-
New Delhi, Delhi, India
- +1 more
Jun 11, 2020
COVID-19 Trial in Puerto Rico, United States (Convalescent Plasma, Masked Saline Placebo)
Terminated
- COVID-19
- Convalescent Plasma
- Masked Saline Placebo
-
Birmingham, Alabama
- +23 more
Sep 9, 2022
COVID-19 Trial in Panama (Multiple doses of anti-SARS-CoV-2 Convalescent Plasma)
Completed
- COVID-19
- Multiple doses of anti-SARS-CoV-2 Convalescent Plasma
-
Panama, Panama1. Complejo Hospitalario Metropolitano Arnulfo Arias Madrid, Caj
Oct 24, 2022
Covid19, Mechanical Ventilation Complication, Corona Virus Infection Trial in Belgium (Convalescent Plasma, Standard of Care)
Active, not recruiting
- Covid19
- +4 more
- Convalescent Plasma
- Standard of Care
-
Ottignies, Brabant Wallon, Belgium
- +16 more
Jan 26, 2023
Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment
Recruiting
- COVID-19 Convalescent Plasma Treatment
-
Strasbourg, FranceService des Maladies Infectieuses et Tropicales - CHU de Strasbo
Jun 15, 2023
COVID-19 Infection in Patients Receiving Anti-CD20 Therapy
Active, not recruiting
- COVID-19
- +3 more
- Convalescent Plasma
-
Rochester, MinnesotaMayo Clinic
Jul 15, 2022